Locations
Cambridge, UK · Streetly End, Cambridge CB21 4RP, UK
industry
Biotechnology · DeepTech
Size
51-200 employees
Stage
Series C+
founded in
2014
Healx is a rare disease biotechnology company that uses generative AI for drug discovery. Healx utilizes advanced artificial intelligence (AI) and machine learning technologies to identify potential drug candidates and repurpose existing drugs for new therapeutic applications. By focusing on drug repurposing, Healx aims to find new uses for existing medications, leveraging their known safety profiles and reducing the risk and cost associated with developing new drugs from scratch.
Something looks off?On-site & Remote